Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 61-70 of 274

Page
per page
  1. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  2. BGJ398
    A3014 BGJ398
     1 Citation
    Target: FGFR
    Summary: FGFR inhibitor ,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
  3. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  4. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  5. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  6. PD 0332991 (Palbociclib) HCl
    A8316 PD 0332991 (Palbociclib) HCl
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥14.48 mg/mL
  7. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  8. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  9. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  10. Temozolomide
    B1399 Temozolomide
    Summary: DNA methylating, chemotherapeutic agent
      insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL

Items 61-70 of 274

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 5item
  3. Chromatin/Epigenetics 28item
  4. Metabolism 1 item
  5. MAPK Signaling 20item
  6. Tyrosine Kinase 85item
  7. DNA Damage/DNA Repair 25item
  8. PI3K/Akt/mTOR Signaling 38item
  9. Microbiology & Virology 2item
  10. Cell Cycle/Checkpoint 54item
  11. Ubiquitination/ Proteasome 3item
  12. JAK/STAT Signaling 23item
  13. TGF-β / Smad Signaling 26item
  14. Angiogenesis 1 item
  15. GPCR/G protein 3item
  16. Stem Cell 6item
  17. Membrane Transporter/Ion Channel 3item
  18. Others 17item
  19. Immunology/Inflammation 2item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 2item
  3. PI3K 14item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 8item
  8. AP-1 1 item
  9. FLT3 8item
  10. GSK-3 7item
  11. PLK 4item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 19item
  15. PDGFR 14item
  16. c-Kit 6item
  17. RET 3item
  18. IRAK 2item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. Thymidylate Synthase 1 item
  21. p38 6item
  22. PKB 1 item
  23. JNK 2item
  24. SGK 2item
  25. Bcr-Abl 10item
  26. MEK 4item
  27. FGFR 6item
  28. Pim 4item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 8item
  32. Trk Receptors 2item
  33. STAT 3item
  34. EGFR 10item
  35. ROCK 6item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 9item
  41. Syk 5item
  42. DNA-PK 6item
  43. AMPK 2item
  44. PDHK 1 item
  45. Topoisomerases 5item
  46. ErbB 2item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. DNA Methyltransferases 3item
  50. ERK 2item
  51. c-MET 5item
  52. PKC 5item
  53. Ubiquitin-specific proteases 1 item
  54. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  55. Lyn 1 item
  56. HER2 2item
  57. Pyk2 3item
  58. LRRK2 3item
  59. Insulin and Insulin-like Receptors 2item
  60. ALK 3item
  61. ROS1 1 item
  62. Sphingosine kinases (SphKs) 1 item
  63. PKG 1 item
  64. PKA 1 item
  65. Myosin light chain kinases (MLCKs) 2item
  66. CaM-KK 1 item
  67. MELK 1 item
  68. Insulin-like growth factors (IGFs) 1 item
  69. Clk 1 item
  70. NUAK1 1 item
  71. NUAK2 1 item
  72. MK2 2item
  73. Fatty-acid-binding proteins (FABPs) 1 item
  74. Tie-2 2item
  75. RSK 1 item
  76. ATM/ATR 4item
  77. CK1 1 item
  78. Farnesyl Diphosphate Synthases 1 item
  79. CK2 3item
  80. HIPK2 1 item
  81. HIPK3 1 item
  82. P2X Receptors 1 item
  83. BLM 1 item
  84. HSV 1 item
  85. Synthases/Synthetases 2item
  86. MAGL 1 item
  87. c-Fyn 1 item
  88. TAK1 1 item
  89. P110 1 item
  90. Hck 1 item
  91. RNA Polymerases 1 item
  92. Insulin Receptors 1 item
  93. IRG-1R 1 item
  94. eEF-2 1 item
  95. Cdc7 1 item
  96. CMV 1 item
  97. ZAP-70 1 item
  98. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  99. Cytidine deaminases 1 item
  100. c-RET 1 item
  101. p70 rsk 1 item
  102. TAM kinase 1 item
  103. AXL 1 item
  104. c-Fms tyrosine kinase 1 item
  105. STK 1 item
  106. MSK 1 item
  107. Lyn kinase 1 item
  108. ITK 1 item
  109. NUAK 1 item
  110. DCLK2 1 item
  111. Lck 1 item
  112. PKD 1 item
  113. tropomyosin receptor kinase 1 item
  114. SK 1 item
  115. ATM 2item
  116. Sirtuin 1 item
  117. PIKfyve 1 item
  118. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 240item
  2. Cell Experiments 150item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 16item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Advanced Renal Cell Carcinoma 1 item
  6. Bladder Cancer 5item
  7. Bladder Carcinoma 2item
  8. Bladder Diseases 1 item
  9. B-lymphoid Malignancies 1 item
  10. Breast Cancer 49item
  11. Cancer 182item
  12. Cervical Cancer 5item
  13. Cholangiocarcinoma 2item
  14. Chronic Lymphocytic Leukemia 2item
  15. Clear Cell Renal Cell Carcinoma 1 item
  16. Colon Cancer 24item
  17. Colon Carcinoma 2item
  18. Colorectal Cancer 22item
  19. Glioblastoma 18item
  20. Glioma 6item
  21. Hepatocellular Carcinoma 5item
  22. HIV Infections 2item
  23. Immunological Diseases 1 item
  24. Inflammatory Bowel Disease 1 item
  25. Inflammatory Diseases 5item
  26. Leukemia 10item
  27. Liver Cancer 3item
  28. Lung Cancer 17item
  29. Lung Carcinoma 3item
  30. Lymphoma 11item
  31. Mantle Cell Lymphoma 1 item
  32. Melanoma 15item
  33. Multiple Myeloma 7item
  34. Myelofibrosis 1 item
  35. Myeloma 2item
  36. Neuroblastoma 3item
  37. Non-small Cell Lung Cancer 5item
  38. Non-small Cell Lung Carcinoma 1 item
  39. Ovarian Cancer 19item
  40. Pancreatic Cancer 24item
  41. Prostate Cancer 21item
  42. Psoriasis 1 item
  43. Pulmonary Arterial Hypertension 1 item
  44. Renal Cancer 3item
  45. Renal Cell Carcinoma 5item
  46. Rheumatoid Arthritis 5item
  47. Sarcoma 1 item
  48. Squamous Cell Carcinoma 1 item
  49. Testicular Cancer 2item
  50. Thyroid Cancer 5item
  51. Type 2 Diabetes 3item